Talk:Valvular heart disease

Wiki Education Foundation-supported course assignment

edit

  This article was the subject of a Wiki Education Foundation-supported course assignment, between 18 November 2019 and 14 December 2019. Further details are available on the course page. Student editor(s): Segregg. Peer reviewers: Bdbwiki1990.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 12:14, 17 January 2022 (UTC)Reply

Work Plan 2019

edit

Hi folks, I'm a 4th year medical student and I'll be working on updates to this page as a part of an elective course at MUSC. I will be using the wikiproject medicine manual of style, and will be sure that my sources adhere to the WP:MEDRS. Specifically I think the page probably should be rearranged according to the content sections described in the WP:MEDMOS. I'm not sure if these sections should be sub-sectioned based on the valve involved or not, if anyone has any strong opinions, feel free to let me know. I think the table in the comparison was a good thought, but it seems a little difficult to read given the size.
I will prioritize updating the diagnosis, treatment, and epidemiology sections in particular. If available, I think chest X-rays and EKGs could be helpful multimedia to add in the diagnosis section.
I plan on updating treatment guidelines based on the 2017 updated Guideline for the Management of Patients with Valvular Heart Disease. I will use additional sources that include Harrison's Principles of Internal Medicine (20th ed) and the 2019 AATS/ACC/ASE/SCAI/STSExpert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease.
I will include information about the diseases that will be relevant to the general public (especially in causes, signs/symptoms subheadings), but will try not to restate what is already in the articles for the specific valvular disorders. I'll continue to link to other existing Wikipedia articles that are relevant. I'll also focus on using clear language and avoiding medical jargon, and will review some patient-directed resources that can help me rephrase if necessary.
Segregg (talk) 20:43, 18 November 2019 (UTC)Reply


Sounds like a good plan! --Emilybrennan (talk) 13:57, 25 November 2019 (UTC)Reply

Content removed

edit

The following content was removed:

In March 29, 2007, pergolide, a dopamine agonist used in treatment of Parkinson's disease and also off label for Restless legs syndrome (RLS), was withdrawn from the US market due to implication in valvular heart disease [1]. The withdrawal was based on findings published in New England Journal of Medicine, confirming previous reports associating pergolide with increased risk of regurgitation of the mitral valve, tricuspid valve, and aortic valve of the heart. Cabergoline, a similar ergot-derived dopamine agonist, is still marketed in EU.
Ergot derivatives (ergotamines) have been implicated in fibrosis not only of the heart valves but also of the pleura and retroperitoneum [2] and possibly other locations.

This is a typical Wikipedia phenomenon - just because this discovery was made after 2001 it is mentioned with massive prominence in an article that is otherwise nothing more than a list. I am removing it temporarily per WP:WEIGHT considerations until the page is more mature. JFW | T@lk 11:52, 13 January 2008 (UTC)Reply

European guidelines

edit

... are a lot shorter - just 39 pages. doi:10.1093/eurhartj/ehl428 JFW | T@lk 12:37, 21 January 2008 (UTC)Reply

Skumin syndrome

edit

Skumin syndrome was added to the intro. Perhaps it ought to be mentioned somewhere, but not in the lead. JFW | T@lk 06:17, 24 October 2011 (UTC)Reply

It seems PMID 7392405 is the relevant reference. On the whole, I don't think the eponym is in widespread use outside Russia. JFWUser_talk:Jfdwolff|T@lk 06:18, 24 October 2011 (UTC)Reply

Pregnancy

edit

A table of the 'Valvular heart lesions associated with high maternal and fetal risk during pregnancy' seems like a better format than the list.

I realize that the citations in the pregnancy section have increasing numbers but all point to the same source. — Preceding unsigned comment added by Triggity (talkcontribs) 16:53, 10 January 2013 (UTC)Reply

AHA/ACC guideline 2014

edit

Bigger than ever:

The DOIs will be switched on eventually... JFW | T@lk 06:18, 10 June 2014 (UTC)Reply

Review of drug therapy

edit

doi:10.1161/CIRCULATIONAHA.115.016006 JFW | T@lk 09:05, 21 September 2015 (UTC)Reply

Updated American guideline

edit

doi:10.1161/CIR.0000000000000503 JFW | T@lk 09:42, 21 June 2017 (UTC)Reply

Peer Review for Segregg

edit

Overall, this article is written well and in a way that reads simply. I did not feel that the content was biased at any point when reading and the sources provided are reliable. Additionally, one of the strengths of this article is the organization of the contents and succinct explanations of the different types of valvular heart diseases. The lead section is broad and to the point. I actually prefer that the written portion is brief and that this section ends with a very organized content table that leads the reader into a very clear outline of the main points made in the article.

You have done an excellent job adding many reputable sources to this page. I do think that there are large parts of discussion where no sources have been included (examples: “Types” lead introduction, “aortic and mitral valve disorders”). Some of this is due to a more definitional description of terms, like “stenosis”, but I do think there is room for improvement here. A few sections could still be expanded upon, such as “Dysplasia” and “Epidemiology”, but overall, the content of this article is very helpful.

You discussed in your talk page the comparison table is difficult to read and I agree with you. The content within it is helpful, but also very dense and it seems to be overwhelming and in ways takes away from the rest of the clean, concise aspects of this article.

Finally, I really liked reading the "treatment" section. The opening line is very succinct and easy to read, while each section that discusses the specific diseases is clear and to the point. Bdbwiki1990 (talk) 15:26, 9 December 2019 (UTC)Reply

Comparison

edit

I am planning on removing this section from the page and redistributing the information elsewhere in the page, but wanted to leave the section here in case anyone wanted to reference it or put it back in. -Segregg (talk) 16:53, 12 December 2019 (UTC)Reply

The following table includes the main types of valvular stenosis and regurgitation. Major types of valvular heart disease not included in the table include mitral valve prolapse, rheumatic heart disease and endocarditis.

Valvular disease Mitral stenosis Aortic stenosis Aortic regurgitation Mitral regurgitation Tricuspid regurgitation
Prevalence Most common valvular heart disease in pregnancy[1] Approximately 2% of people over the age of 65, 3% of people over age 75, and 4% percent of people over age 85[2] 2% of the population, equally in males and females.[3]
Main causes and risk factors Almost always caused by rheumatic heart disease[4]

Hypertension, diabetes mellitus, hyperlipoproteinemia and uremia may speed up the process.[5]

Acute

Chronic

Acute

Chronic

Hemo
dynamics

/
Patho-
physiology
Progressive obstruction of the mitral ostium causes increased pressure in the left atrium and the pulmonary circulation.[5] Congestion may cause thromboembolism, and atrial hypertension may cause atrial fibrillation.[5] Obstruction through the aortic ostium causes increased pressure in the left ventricle and impaired flow through the aorta Insufficiency of the aortic valve causes backflow of blood into the left ventricle during diastole. Insufficiency of the mitral valve causes backflow of blood into the left atrium during systole. Insufficiency of the tricuspid valve causes backflow of blood into the right atrium during systole.
Symptoms

Symptoms increase with exercise and pregnancy[4]

Medical signs

Signs increase with exercise and pregnancy[4]

In acute cases, the murmur and tachycardia may be only distinctive signs.[5]

Diagnosis
  • Chest X-ray showing calcific aortic valve, and in longstanding disease, enlarged left ventricle[4][5] and atrium[4]
  • ECG showing left ventricular hypertrophy and left atrial abnormality[4]
  • Echocardiography is diagnostic in most cases, showing left ventricular hyperthrophy, thickened and immobile aortic valve and dilated aortic root,[4] but may appear normal if acute[5]
  • Cardiac chamber catheterization provides a definitive diagnosis, indicating severe stenosis in valve area of <0.8 cm2 (normally 3 to 4 cm2). It is useful in symptomatic patients before surgery.[4]
  • Chest X-ray showing left ventricular hypertrophy and dilated aorta[4]
  • ECG indicating left ventricular hypertrophy[4]
  • Echocardiogram showing dilated left aortic root and reversal of blood flow in the aorta. In longstanding disease there may be left ventricular dilatation. In acute aortic regurgitation, there may be early closure of the mitral valve.[4]
  • Cardiac chamber catetherization assists in assessing the severity of regurgitation and any left ventricular dysfunction[4]
  • Chest X-ray showing dilated left ventricle[4]
  • Echocardiography to detect mitral reverse flow, dilated left atrium and ventricle and decreased left ventricular function[4]
Treatment

No therapy is required for asymptomatic patients. Diuretics for any pulmonary congestion or edema.[4] If stenosis is severe, surgery is recommended.[4] Any atrial fibrillation is treated accordingly.[4]

No treatment in asymptomatic patients.[4]

Medical therapy and percutaneous balloon valvuloplasty have relatively poor effect.[4]
- Any angina is treated with short-acting nitrovasodilators, beta-blockers and/or calcium blockers[5]
- Any hypertension is treated aggressively, but caution must be taken in administering beta-blockers[5]
- Any heart failure is treated with digoxin, diuretics, nitrovasodilators and, if not contraindicated, cautious inpatient administration of ACE inhibitors[5]

Also, endocarditis prophylaxis is indicated before dental, gastrointestinal or genitourinary procedures.[4]

Follow-up
  • In moderate cases, echocardiography every 1–2 years, possibly complemented with cardiac stress test.[5] Immediate revisit if new related symptoms appear.[5]
  • In severe cases, echocardiography every 3–6 months.[5] Immediate revisit or inpatient care if new related symptoms appear.[5]
  • In mild to moderate cases, echocardiography and cardiac stress test every 1–2 years[5]
  • In severe moderate/severe cases, echocardiography with cardiac stress test and/or isotope perfusion imaging every 3–6 months.[5]
  • In mild to moderate cases, echocardiography and cardiac stress test every 1–3 years.[5]
  • In severe cases, echocardiography every 3–6 months.[5]

Diagnostic classification of aortic stenosis

edit

Hello: I think the classification is wrong. It's the other way around. --Ortisa (talk) 15:39, 23 June 2020 (UTC)Reply

References

edit
  1. ^ Gelson, E.; Gatzoulis, M.; Johnson, M. (2007). "Valvular heart disease". BMJ (Clinical Research Ed.). 335 (7628): 1042–1045. doi:10.1136/bmj.39365.655833.AE. PMC 2078629. PMID 18007005.
  2. ^ Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997; 29: 630-634.
  3. ^ The Cleveland Clinic Center for Continuing Education > Mitral Valve Disease: Stenosis and Regurgitation Archived 2010-09-21 at the Wayback Machine Authors: Ronan J. Curtin and Brian P. Griffin. Retrieved September 2010
  4. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by bz ca cb cc cd ce cf cg ch ci cj ck cl cm cn co cp cq cr cs ct cu cv cw cx cy cz da db dc dd Chapter 1: Diseases of the Cardiovascular system > Section: Valvular Heart Disease in: Elizabeth D Agabegi; Agabegi, Steven S. (2008). Step-Up to Medicine (Step-Up Series). Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 978-0-7817-7153-5.
  5. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au VOC=VITIUM ORGANICUM CORDIS, a compendium of the Department of Cardiology at Uppsala Academic Hospital. By Per Kvidal September 1999, with revision by Erik Björklund May 2008
  6. ^ "Aortic Dissection. Acute Aortic Dissection Information. Patient". patient.info. Retrieved 2018-11-23.